Olgu Sunumu
BibTex RIS Kaynak Göster

F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up

Yıl 2022, Cilt: 2 Sayı: 1, 1 - 2, 15.04.2022

Öz

Ameloblastoma is a benign odontogenic tumor that originate from dental region (1). Previous reports have determined the F-18 FDG PET/CT findings of this tumor (1) and this is the first case with follow up results in the literature as far as we know.

Kaynakça

  • Seno S, Kitajima K, Inokuchi G, Nibu K, Itoh T, Ejima Y, Sasaki R, Sugimoto K, Sugimura K. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015;4:250.
  • Inoue N, Shimojyo M, Iwai H, Ohtsuki H, Yasumizu R, Shintaku M, Taniguchi N, Inada M, Arika T, Morita S, et al. Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature. Am J Clin Pathol. 1988;90(4):474-81
  • Devenney-Cakir B, Dunfee B, Subramaniam R, Sundararajan D, Mehra P, Spiegel J, Sakai O. Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography. Dentomaxillofac Radiol. 2010;39(7):449-53Iban, M. C. (2020). Geospatial data science response to COVID-19 crisis and pandemic isolation tracking. Turkish Journal of Geosciences, 1(1), 1-7.
  • Nguyen BD. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging. Clin Nucl Med. 2005 Jun;30(6):450-2Yakar, M., Yılmaz, H. M., & Mutluoglu, O. (2014). Performance of photogrammetric and terrestrial laser scanning methods in volume computing of excavation and filling areas. Arabian Journal for Science and Engineering, 39, 387-394.
  • Otsuru M, Aoki T, Tsukinoki K, Ota Y, Karakida K, Yamazaki H, Yasuda M, Kaneko A. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression. J Oral Maxillofac Surg. 2008 Aug;66(8):1761-5.
Yıl 2022, Cilt: 2 Sayı: 1, 1 - 2, 15.04.2022

Öz

Kaynakça

  • Seno S, Kitajima K, Inokuchi G, Nibu K, Itoh T, Ejima Y, Sasaki R, Sugimoto K, Sugimura K. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015;4:250.
  • Inoue N, Shimojyo M, Iwai H, Ohtsuki H, Yasumizu R, Shintaku M, Taniguchi N, Inada M, Arika T, Morita S, et al. Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature. Am J Clin Pathol. 1988;90(4):474-81
  • Devenney-Cakir B, Dunfee B, Subramaniam R, Sundararajan D, Mehra P, Spiegel J, Sakai O. Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography. Dentomaxillofac Radiol. 2010;39(7):449-53Iban, M. C. (2020). Geospatial data science response to COVID-19 crisis and pandemic isolation tracking. Turkish Journal of Geosciences, 1(1), 1-7.
  • Nguyen BD. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging. Clin Nucl Med. 2005 Jun;30(6):450-2Yakar, M., Yılmaz, H. M., & Mutluoglu, O. (2014). Performance of photogrammetric and terrestrial laser scanning methods in volume computing of excavation and filling areas. Arabian Journal for Science and Engineering, 39, 387-394.
  • Otsuru M, Aoki T, Tsukinoki K, Ota Y, Karakida K, Yamazaki H, Yasuda M, Kaneko A. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression. J Oral Maxillofac Surg. 2008 Aug;66(8):1761-5.
Toplam 5 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Onkoloji ve Karsinogenez
Bölüm Case Reports
Yazarlar

Zehra Pınar Koç Bu kişi benim 0000-0002-3274-5790

Pınar Pelin Özcan Bu kişi benim 0000-0003-0147-2678

Emel Sezer Bu kişi benim 0000-0001-9881-3533

Gökçe Yavan Bu kişi benim 0000-0002-7332-6293

Yayımlanma Tarihi 15 Nisan 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 2 Sayı: 1

Kaynak Göster

APA Koç, Z. P., Özcan, P. P., Sezer, E., Yavan, G. (2022). F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging, 2(1), 1-2.
AMA Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. Nisan 2022;2(1):1-2.
Chicago Koç, Zehra Pınar, Pınar Pelin Özcan, Emel Sezer, ve Gökçe Yavan. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging 2, sy. 1 (Nisan 2022): 1-2.
EndNote Koç ZP, Özcan PP, Sezer E, Yavan G (01 Nisan 2022) F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging 2 1 1–2.
IEEE Z. P. Koç, P. P. Özcan, E. Sezer, ve G. Yavan, “F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up”, Molecular Oncologic Imaging, c. 2, sy. 1, ss. 1–2, 2022.
ISNAD Koç, Zehra Pınar vd. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging 2/1 (Nisan 2022), 1-2.
JAMA Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. 2022;2:1–2.
MLA Koç, Zehra Pınar vd. “F-18 FDG PET/CT Imaging in the Ameloblastoma Follow Up”. Molecular Oncologic Imaging, c. 2, sy. 1, 2022, ss. 1-2.
Vancouver Koç ZP, Özcan PP, Sezer E, Yavan G. F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging. 2022;2(1):1-2.